Please login or register first to view this content.
Cardiovascular Disease Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Statins Tied to Lower In-Hospital COVID-19 Mortality Risk
A Review of Treatments for HFrEF and Expert Q&A
USPSTF Finds Evidence Lacking for Child HTN Screening
Brilinta Approved to Reduce Risk of Recurrent Stroke in High-Risk Patients
Apabetalone Prevents CV Events in High-Risk Diabetic CKD
Rivaroxaban sNDA Submitted for Symptomatic Peripheral Artery Disease
Certain HTN Meds May Cut Deaths From Influenza, Pneumonia
Neurologic Complications Seen in Hospitalized COVID-19 Patients
Higher Levothyroxine Doses Linked to Afib in Older Patients
Ertugliflozin Noninferior for CV Outcomes in T2DM With ASCVD
FDA Approves New Formulation of Ultomiris for PNH and aHUS
Mixed Results for Omecamtiv Mecarbil in Heart Failure Study
Hydroxychloroquine Not Beneficial for SARS-CoV-2 Preexposure Prophylaxis
Review: Estimated Prevalence of VTE 14.1% in COVID-19
Dapagliflozin Gets Breakthrough Therapy Status for CKD Indication
Major Adverse CV Event Risk Reduced With SGLT2 Inhibitors
Real-World Antihypertensive Prescribing Deviates From Guidelines, Study Says
USPSTF Finds Evidence Lacking for Vitamin D Screening
